ArticleDigital health
Teleassistance for remote home oxygen monitoring in neonates.
Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To evaluate the feasibility and clinical impact of an IoT-based teleassistance system for remote monitoring of preterm neonates receiving home oxygen therapy. Methods: A historically controlled cohort study was conducted in Manizales, Colombia, with three phases: (1) baseline data collection from neonates receiving traditional follow-up (n=32), (2) development of an Internet of Things (IoT)-based teleassistance system integrating physiological monitoring, cloud storage, and mobile applications, and (3) pilot testing in a prospective intervention cohort (n=25). The primary outcome was the duration of home oxygen therapy. Results: Median duration of home oxygen therapy was reduced from 34 days (IQR 25-46) in the control group to 10 days (IQR 7-17) in the intervention group (p<0.001). Reliable communication was achieved through 4G and Wi-Fi, while LoRa performance was limited by geographic constraints. Conclusions: IoT-based teleassistance was associated with a reduction in the duration of home oxygen therapy in preterm neonates and demonstrated feasibility for remote monitoring in resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.